Update on Breast Implant-Associated Lymphoma (BIA-ALCL) and Breast Implant Illness (BII)
FDA Update on Breast Implant-associated Lymphoma and Illness The FDA issued an update to its breast implant safety pages on August 20, 2020 regarding adverse events reported to the agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as well as data regarding “Breast Implant Illness” (BII). The BIA-ALCL update showed […]
